IMMUNIZATIONS – Adds to existing law to establish a moratorium on certain uses of human gene therapy products.

This Idaho bill (S 1346) establishes a two-year moratorium on using human gene therapy products for immunizations in children under 18 and pregnant women. It directly affects healthcare providers and manufacturers who administer such therapies for infectious diseases, prohibiting all routes of administration under this category. Key provisions define "human gene therapy products" broadly (including modified cells and genetic materials) but exclude cancer treatments, genetic disorder therapies, and approved clinical trials. The moratorium requires legislative review of safety data before renewal and includes specific exemptions for compassionate use or clinical trials. The bill aims to pause experimental gene-based immunizations pending safety evaluation.